These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27402599)

  • 21. Predictive responses of periarcuate pursuit neurons to visual target motion.
    Fukushima K; Yamanobe T; Shinmei Y; Fukushima J
    Exp Brain Res; 2002 Jul; 145(1):104-20. PubMed ID: 12070750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primate area MST-l is involved in the generation of goal-directed eye and hand movements.
    Ilg UJ; Schumann S
    J Neurophysiol; 2007 Jan; 97(1):761-71. PubMed ID: 17065255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of nicotine on leading saccades during smooth pursuit eye movements in smokers and nonsmokers with schizophrenia.
    Avila MT; Sherr JD; Hong E; Myers CS; Thaker GK
    Neuropsychopharmacology; 2003 Dec; 28(12):2184-91. PubMed ID: 12968127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.
    Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
    Psychol Med; 2014 Feb; 44(3):633-46. PubMed ID: 23597077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contextual effects on motion perception and smooth pursuit eye movements.
    Spering M; Gegenfurtner KR
    Brain Res; 2008 Aug; 1225():76-85. PubMed ID: 18538748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of acute nicotine on brain function in healthy smokers and non-smokers: estimation of inter-individual response heterogeneity.
    Ettinger U; Williams SC; Patel D; Michel TM; Nwaigwe A; Caceres A; Mehta MA; Anilkumar AP; Kumari V
    Neuroimage; 2009 Apr; 45(2):549-61. PubMed ID: 19159693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study.
    Dépatie L; O'Driscoll GA; Holahan AL; Atkinson V; Thavundayil JX; Kin NN; Lal S
    Neuropsychopharmacology; 2002 Dec; 27(6):1056-70. PubMed ID: 12464463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortical afferents to the smooth-pursuit region of the macaque monkey's frontal eye field.
    Stanton GB; Friedman HR; Dias EC; Bruce CJ
    Exp Brain Res; 2005 Aug; 165(2):179-92. PubMed ID: 15940495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neural responses related to smooth-pursuit eye movements and their correspondence with electrically elicited smooth eye movements in the primate frontal eye field.
    Gottlieb JP; MacAvoy MG; Bruce CJ
    J Neurophysiol; 1994 Oct; 72(4):1634-53. PubMed ID: 7823092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociable and common effects of methylphenidate, atomoxetine and citalopram on response inhibition neural networks.
    Nandam LS; Hester R; Bellgrove MA
    Neuropsychologia; 2014 Apr; 56():263-70. PubMed ID: 24513025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The contribution of the human PPC to the orienting of visuospatial attention during smooth pursuit.
    Drew AS; van Donkelaar P
    Exp Brain Res; 2007 May; 179(1):65-73. PubMed ID: 17221223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia.
    Hong LE; Schroeder M; Ross TJ; Buchholz B; Salmeron BJ; Wonodi I; Thaker GK; Stein EA
    Schizophr Bull; 2011 Mar; 37(2):416-25. PubMed ID: 19713300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences between smooth pursuit and optokinetic eye movements using limited lifetime dot stimulation: a functional magnetic resonance imaging study.
    Schraa-Tam CK; van der Lugt A; Smits M; Frens MA; van Broekhoven PC; van der Geest JN
    Clin Physiol Funct Imaging; 2009 Jul; 29(4):245-54. PubMed ID: 19281500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific motion processing pathway deficit during eye tracking in schizophrenia: a performance-matched functional magnetic resonance imaging study.
    Hong LE; Tagamets M; Avila M; Wonodi I; Holcomb H; Thaker GK
    Biol Psychiatry; 2005 Apr; 57(7):726-32. PubMed ID: 15820229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinguishing subregions of the human MT+ complex using visual fields and pursuit eye movements.
    Dukelow SP; DeSouza JF; Culham JC; van den Berg AV; Menon RS; Vilis T
    J Neurophysiol; 2001 Oct; 86(4):1991-2000. PubMed ID: 11600656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. And yet it moves: perceptual illusions and neural mechanisms of pursuit compensation during smooth pursuit eye movements.
    Furman M; Gur M
    Neurosci Biobehav Rev; 2012 Jan; 36(1):143-51. PubMed ID: 21616092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissociation of saccade-related and pursuit-related activation in human frontal eye fields as revealed by fMRI.
    Petit L; Clark VP; Ingeholm J; Haxby JV
    J Neurophysiol; 1997 Jun; 77(6):3386-90. PubMed ID: 9212283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contribution of the human FEF and SEF to smooth pursuit initiation.
    Drew AS; van Donkelaar P
    Cereb Cortex; 2007 Nov; 17(11):2618-24. PubMed ID: 17255110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional anatomy of pursuit eye movements in humans as revealed by fMRI.
    Petit L; Haxby JV
    J Neurophysiol; 1999 Jul; 82(1):463-71. PubMed ID: 10400972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.